DVA

Historical Earnings Track Record: Beats and Drift

Over the last eight reported quarters, DVA has beaten the official consensus in five of them, a 62% beat rate, with an average earnings surprise of 1.7%. Across those same quarters, the average five-trading-day price move after the report is 10.3%, classified as an “up” drift. That tells you DVA has tendency for multi-day continuation when the reaction is favorable, but the average is not the whole story. The four most recent quarters show wide dispersion. On 2026-05-05, DVA reported actual EPS of $2.87 against an estimate of $2.41, a 19.1% beat, and the stock moved 23.46% the next day and 27.7% over the following five days. Three months earlier, on 2026-02-02, actual EPS of $3.40 beat the $3.24 estimate by 4.9%, producing a 21.17% next-day move and 23.79% over five days. But on 2025-10-29, actual EPS of $2.51 missed the $3.17 estimate by -20.8%, sending the stock -6.17% the next day and -4.27% over five days. Most instructive is 2025-08-05: DVA beat the $2.70 estimate by 9.3% with actual EPS of $2.95, yet the stock fell -9.04% the next day and -6.01% over five days. So a beat does not guarantee a rally, and the 10.3% average five-day drift is driven by a few very large post-earnings gaps.

Options-Flow Dynamics Around the Aug. 4 Report

DVA’s next scheduled earnings release is 2026-08-04 after the close, with the official consensus EPS estimate at $3.88. Heading into that report, DVA is priced at $235.44, with an RSI of 64.3 and a 50-day EMA of $212.61. A 10.3% post-earnings drift expectation, applied to the current price, implies a directional notional move of roughly $24.25 per share, which creates a wide options-implied trading range. Because the stock is well above its 50-day EMA and RSI is near traditional overbought territory, demand for puts as hedges can rise alongside call speculation, potentially inflating implied volatility. Market makers who are short gamma may be forced to hedge more aggressively into the print, which can exaggerate the post-release move beyond what the EPS number alone would suggest. Traders can watch for unusual volume in the August 7 and August 14 expiry contracts, shifts in at-the-money straddle pricing, and whether open interest builds above or below current strikes. As a Healthcare/Medical - Care Facilities name, DVA can also see intraday repricing around Medicare reimbursement or patient-volume commentary, which adds another layer to options-flow positioning.

What a Disciplined Trader Watches

A disciplined trader frames DVA’s earnings setup around the 5/8 (62%) beat rate and the 1.7% average surprise, but does not assume that either one predicts the price direction. The key comparison is how the actual EPS lands against the $3.88 consensus and, just as importantly, how management guidance compares to the market's real expectation. The historical extremes give useful guardrails: a large next-day upside move could resemble the 23.46% reaction on 2026-05-05 or the 21.17% reaction on 2026-02-02, while downside reactions have ranged from -6.17% to -9.04% even on quarters with different headline results. Technically, the $212.61 50-day EMA is a natural reference point if post-earnings selling appears, while current levels near $235.44 with an RSI of 64.3 suggest the stock is already advanced. Over the five sessions after the report, compare the realized move with the historical 10.3% five-day up-drift average. If price action contradicts the headline beat or miss, that divergence can be more informative than the number itself. Also watch for sector-specific guidance, payer mix changes, or commentary on volume trends.

For a deeper dive into how analysts, institutions, and proprietary models are positioned for the Aug. 4 report, look at the full institutional verdict on the platform.